Mixed-Reality Radiation Planning Market Report 2026

The mixed-reality radiation planning market size has grown exponentially in recent years. It will grow from $1.75 billion in 2025 to $2.28 billion in 2026 at a compound annual growth rate (CAGR) of 30.2%. The growth in the historic period can be attributed to increasing adoption of advanced imaging tools, growing integration of ar and vr in clinical workflows, rising focus on precise radiation planning, expanding use of 3D anatomical visualization, increasing demand for patient-specific treatment planning.

The mixed-reality radiation planning market size is expected to see expoential growth in the next few years. It will grow to $6.48 billion in 2030 at a compound annual growth rate (CAGR) of 29.9%. The growth in the forecast period can be attributed to growing investment in mixed-reality healthcare solutions, increasing adoption of immersive planning tools, rising demand for high-precision radiation therapy, expanding use of real-time visualization technologies, increasing integration of ai with mixed-reality systems. Major trends in the forecast period include technology advancements in mixed-reality platforms, innovations in immersive treatment planning tools, developments in real-time imaging integration, research and development in vr/ar-based medical applications, advancements in motion-adaptive visualization systems.

The increasing prevalence of cancer is expected to drive the growth of the mixed-reality radiation planning market in the coming years. Cancer is a condition marked by the uncontrolled growth and spread of abnormal cells, which can damage surrounding tissues and organs if not treated effectively. The incidence of cancer is rising due to lifestyle-related risk factors such as unhealthy diets, smoking, alcohol consumption, and exposure to environmental pollutants, all of which increase the likelihood of developing various cancers. Mixed-reality radiation planning supports cancer management by enabling interactive, three-dimensional visualization of patient anatomy and tumor positioning, allowing for more precise treatment planning. It enhances patient outcomes by improving accuracy, minimizing radiation exposure to healthy tissues, and enabling more effective therapy delivery. For example, in October 2025, according to NHS Digital, a UK government organization, 354,820 new cancer diagnoses were recorded in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022, with prostate cancer being the most frequently diagnosed cancer at 58,137 new cases, reflecting a 6% rise in registrations compared with the previous year. Therefore, the growing prevalence of cancer is contributing to the expansion of the mixed-reality radiation planning market.

Major companies operating in the mixed-reality radiation planning market are concentrating on developing advanced solutions, such as AI-powered CT and MR systems, to improve treatment accuracy, enhance clinical workflow efficiency, and lower operational costs and environmental impact. AI-powered CT and MR systems are advanced diagnostic platforms that leverage artificial intelligence to enhance image quality, speed up workflows, and support more precise planning for treatments such as radiation therapy. For example, in September 2025, Royal Philips, a Netherlands-based health technology company, introduced the Rembra RT and Areta RT CT platforms along with the helium-free BlueSeal RT 1.5T MR system. These systems are designed to establish new benchmarks in precision cancer care by incorporating innovations such as AI-driven detectors for clearer tumor visualization and sustainable helium-free operation. They also feature ultra-fast image processing and workflow optimizations that enable care teams to operate more efficiently while delivering dependable long-term value through capabilities such as extended service life guarantees.

In March 2024, apoQlar GmbH, a Germany-based medical XR software company, entered into a partnership with Mayo Clinic to integrate extended reality (XR) technology into radiation therapy planning and patient care workflows. Through this collaboration, apoQlar GmbH and Mayo Clinic aim to improve radiation planning accuracy, strengthen interdisciplinary treatment coordination, and enhance patient engagement by utilizing immersive XR tools that visualize complex anatomical data in real time. Mayo Clinic is a US-based private academic medical center dedicated to integrated healthcare, education, and research.

Major companies operating in the mixed-reality radiation planning market are Microsoft Corporation, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Varian Medical Systems, Elekta AB, Brainlab AG, Magic Leap Inc., Materialise NV, Canon Medical Systems Corporation, C‑RAD AB, Medivis Inc., Surgical Theater Inc., Koninklijke Philips N.V., ImmersiveTouch Inc., EchoPixel Inc., Hindsyt, Spectronic Medical AB, ViewRay Inc.

North America was the largest region in mixed reality radiation planning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mixed-reality radiation planning market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mixed-reality radiation planning market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the mixed reality radiation planning market by increasing costs of imported head-mounted displays, high-performance workstations, tracking sensors, and specialized medical software hardware. hospitals and cancer treatment centers in north america and europe are most affected due to reliance on imported advanced visualization equipment, while asia-pacific faces higher system deployment costs. these tariffs are increasing implementation budgets and slowing technology upgrades. however, they are also encouraging local system integration, regional software development, and partnerships between healthcare providers and technology vendors.

The mixed reality radiation planning market refers to the area of healthcare technology that applies augmented, virtual, and mixed-reality tools to support clinicians in visualizing tumors, adjacent anatomy, and radiation dose distributions during treatment planning. It combines 3D holographic imaging, real-time simulation, and immersive collaborative capabilities to enhance precision, improve workflow efficiency, and support clinician training in radiation oncology.

The primary components of mixed-reality radiation planning systems include hardware, software, and services. Hardware includes head-mounted visualization tools that enable immersive 3D modeling of patient anatomy and radiation plans. Technologies include virtual reality, mixed reality, and augmented reality, deployed on on-premises, cloud, and hybrid models. Applications span oncology, radiology, surgery, and medical training, across hospitals, cancer centers, research institutions, and others.

The mixed-reality radiation planning market consists of revenues earned by entities by providing services such as 3D visualization of patient anatomy, treatment plan simulation, real-time interactive radiation dose planning, clinician training and rehearsal, workflow optimization, and integration of mixed-reality tools. The market value includes the value of related goods sold by the solution provider or integrated within the planning tools. Only goods and services traded between entities or sold to end consumers are included. The mixed-reality radiation planning market consists of sales of mixed-reality headsets and devices, 3D visualization and simulation software, interactive treatment planning platforms, holographic imaging systems, and integrated hardware-software solutions. Values in this market are ‘factory gate’ values, reflecting the value of goods sold by the manufacturers or creators of these tools, whether to other entities or directly to end customers. The value of goods in this market includes related services sold by the creators of the tools.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.